Drugs / Platelet Rich plasma (PRGF)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02365142 Comparator | Jun 2014 → Jun 2018 | osteoarthritis, knee | Clinica Universidad de Navarra, Universidad de Navarra | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet Rich plasma (PRGF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02365142 ↗ |
| Known as | PRGF | “Here, we evaluated the clinical effects of a dose of 100 × 106 bone marrow mesenchymal stromal cells (BM-MSCs) in combination with Platelet Rich Plasma (PRGF®) as adjuvant in a...” PMID 32948200 ↗ Sep 2020 |
| Route | Other | “3 intra-articular injections of platelet richa plasma (PRGF®) separated by 7 days” NCT02365142 ↗ |